首页> 外文会议>International Gastric Cancer Congress >Impact of H. pylori Eradication on Gastric Atrophy: Current Status of the Japanese Intervention Trial (JITHP Study)
【24h】

Impact of H. pylori Eradication on Gastric Atrophy: Current Status of the Japanese Intervention Trial (JITHP Study)

机译:H.幽门螺杆菌根除对胃萎缩的影响:日本干预审判的现状(JITPP研究)

获取原文

摘要

The Japanese Intervention Trial of H. Pylori (JITHP) was originally designed to elucidate the causal link between H. Pylori, gastric pre-malignant conditions and gastric cancer. However, due to the final number of recruitments the endpoints were reduced to determine the causality between eradication and regression/progression of atrophy. H. pylori positive patients were randomized to receive a seven days course of Lansoprazpl, Claritromycin and Amoxicilin. Atrophy was evaluated endoscopically according to Kimura-Takemoto's classification. Since September 1995, 8322 subjects were screened serologically. Among 4650 positive subjects, 1222 were endoscopically screened.
机译:日本幽门螺杆菌(JITHP)的日本干预试验最初旨在阐明H. Pylori,胃癌患者和胃癌之间的因果关系。但是,由于最终招聘数量,终点被降低,以确定根除和消退/萎缩进展之间的因果关系。 H. Pylori阳性患者随机患者接受七天的LansoPrazpl,Clytromycin和Amoxicilin。根据Kimura-Takemoto的分类,内窥镜评估萎缩。自1995年9月以来,筛选8322名受试者筛查。在4650个阳性受试者中,1222例在内窥镜上筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号